prikaz prve stranice dokumenta Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy
  Preuzmi
PDF 888.93 KB
Znanstveni rad - Izvorni znanstveni rad
Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy
Scientific Reports, 14 (2024), 1; 7227. https://doi.org/10.1038/s41598-024-57871-9
Dimnjaković, Jelena; Buble, Tamara; Ivanko, Pero; Pristaš, Ivan; Brborović, Ognjen; Brborović, Hana

Citirajte ovaj rad

Dimnjaković, J., Buble, T., Ivanko, P., Pristaš, I., Brborović, O. i Brborović, H. (2024). Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy. Scientific Reports, 14. (1). doi: 10.1038/s41598-024-57871-9

Dimnjaković, Jelena, et al. "Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy." Scientific Reports, vol. 14, br. 1, 2024. https://doi.org/10.1038/s41598-024-57871-9

Dimnjaković, Jelena, Tamara Buble, Pero Ivanko, Ivan Pristaš, Ognjen Brborović i Hana Brborović. "Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy." Scientific Reports 14, br. 1 (2024). https://doi.org/10.1038/s41598-024-57871-9

Dimnjaković, J., et al. (2024) 'Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy', Scientific Reports, 14(1). doi: 10.1038/s41598-024-57871-9

Dimnjaković J, Buble T, Ivanko P, Pristaš I, Brborović O, Brborović H. Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy. Scientific Reports [Internet]. 27.03.2024. [pristupljeno 09.11.2024.];14(1). doi: 10.1038/s41598-024-57871-9

J. Dimnjaković, T. Buble, P. Ivanko, I. Pristaš, O. Brborović i H. Brborović, "Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy", Scientific Reports, vol. 14, br. 1, Ožujak 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:920092. [Citirano: 09.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:920092
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy
AutorJelena Dimnjaković
AutorTamara Buble
AutorPero Ivanko
AutorIvan Pristaš
AutorOgnjen Brborović
AutorHana Brborović
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA SOCIJALNU MEDICINU I ORGANIZACIJU ZDRAVSTVENE ZAŠTITE)
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA ZDRAVSTVENU EKOLOGIJU, MEDICINU RADA I SPORTA)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Javno zdravstvo i zdravstvena zaštita
Zdravstvena ekologija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Javno zdravstvo i zdravstvena zaštita
Socijalna medicina
Sažetak (engleski)
There is a scarcity of information on the population with diabetes mellitus type 2 and cardiomyopathy (PDMC) in COVID-19, especially on the association between anti-diabetic medications and COVID-19 outcomes. Study is designed as a retrospective cohort analysis covering 2020 and 2021. Data from National Diabetes Registry (CroDiab) were linked to hospital data, primary healthcare data, the SARS-CoV-2 vaccination database, and the SARS-CoV-2 test results database. Study outcomes were cumulative incidence of SARS-CoV-2 positivity, COVID-19 hospitalizations, and COVID-19 deaths. For outcome predictors, logistic regression models were developed. Of 231 796 patients with diabetes mellitus type 2 in the database, 14 485 patients had cardiomyopathy. The two2-year cumulative incidence of all three studies' COVID-19 outcomes was higher in PDMC than in the general diabetes population (positivity 15.3% vs. 14.6%, p = 0.01; hospitalization 7.8% vs. 4.4%, p 
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaScientific Reports
Brojčani podacivol. 14, br. 1, 7227
e-ISSN2045-2322
DOIhttps://doi.org/10.1038/s41598-024-57871-9
URN:NBNurn:nbn:hr:105:920092
Datum objave publikacije2024-03-27
URL dokumentahttps://www.nature.com/articles/s41598-024-57871-9
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2024-10-22 08:47:06